The global Genome Editing market size is expected to be worth around US$ 18.1 billion by 2030, according to a new report by Vision Research Reports.
The global Genome Editing market size was valued at US$ 12.25 billion in 2020 and is anticipated to grow at a CAGR of 23.7% during forecast period 2021 to 2030.
Growth Factors
The use of the technology for disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.
The ability of genome editing therapies to offer a significant improvement over current treatment options is important in enabling editing technologies to capture significant revenue share. Improved efficacy, reduced side effects, and the potential for a cure for specific diseases, can be attributed to induce growth in the coming years.
Moreover, technological advancements with respect to the development of novel vectors for delivery is anticipated to fuel growth in the coming years. Rising competition amongst the operating entities in order to gain a larger share of revenue is also responsible for the projected growth. These companies leverage industry collaborations for the acceleration of diversified product pipelines.
Report Highlights
Given the novelty of the genome editing field, there are many opportunities to optimize the technology. CRISPR, ZFN, and TALENs/MegaTALs are major technologies. PiggyBac, Flp-In, antisense, and Jump-In are the other methods for gene editing and engineering.
CRISPR accounted for the largest share and is expected to dominate the market over the forecast period. Advantages associated with the use of technology such as it can be tailored to treat patient-specific mutations for diseases such as cystic fibrosis are attributive for estimated share.
Ease of control in DNA modification is responsible for the larger share of the ex-vivo method of delivery. Furthermore, the strength and duration of nuclease expression can also be precisely regulated to maximize efficiency and minimize off-target editing.
Owing to the aforementioned advantages, CAR-t technology in the form of ex-vivo products in oncology blood disorders treatment are observed to be prioritized in the therapeutic molecular scissors pipeline. However, a large majority of diseases have to be treated by in vivo delivery as some specialized cells cannot be removed from the body.
Application of this technology for cell line genetic engineering in the form of therapy and gene therapy accounted for the largest share and is anticipated to register lucrative growth.
The use of the technology for the development of novel molecules that can be targeted for treating diseases such as hematological malignancies and infectious diseases is expected to drive the adoption of this technology in the coming years.
Amidst controversy, there is potential growth for the genome editing market in the field of animal genetic modification to understand gene function modification and tracking and expression analysis. The usage of molecular scissors in this vertical is also expected to drive demand over the forecast period.
Biotechnology organizations accounted for the largest share. The presence of a large number of research projects carried out in gene engineering for the development of novel therapeutics is responsible for the share. The other end-users for the technology include academic and government research institutions and contract research organizations.
Academic and government research institutes are expected to witness the fastest growth in the coming years owing to the rising adoption of the technology in university-based projects. The introduction of advancements in the genome engineering sector is anticipated to accelerate its uptake in government research projects.
The solution opted by the market entities is the provision of user-friendly kits and partial services to the stem cell researchers so that engineering can be performed themselves while maintaining the required conditions for pluripotency. High cost associated with the development of infrastructure for the set-up of stem cell conditions for implementation is anticipated to restrain the growth of the outsourcing services in the coming years.
Established companies such as Thermo Fisher and Sigma Aldrich Corporation are engaged in the provision of custom vectors for editing and engineering of cell lines. Outsourcing of these services is expected to increase in the coming years, thus boosting growth.
North America dominated the market in terms of revenue share owing to the higher adoption of advanced techniques in the research institutes based in the U.S. Furthermore, a higher incidence of monogenic diseases in this region is attributive for the estimated share.
For instance, cystic fibrosis is a common, inherited disease that results in severe damage to the lungs and other organs and occurs at a frequency of 1 in 2,500 births in the U.S. Moreover, currently, 122,000 people in the U.S. requiring an organ transplant, a number that is steadily increasing.
Accelerated research in the field of biotechnology and personalized medicine in the economies of Asia Pacific region is expected to boost growth over the forecast period. China is expected to witness the fastest growth in this region.
Key Players
Caribou Biosciences, Inc., Sangamo, Editas Medicine, Recombinetics, Inc, Thermo Fisher Scientific, Inc., CRISPR THERAPEUTICS, Intellia Therapeutics, Inc., and Sigma Aldrich Corporation.
Market Segmentation
Technology Outlook
(CRISPR)/Cas9
TALENs/MegaTALs
ZFN
Others
Delivery Method Outlook
Ex-Vivo
In-Vivo
Application Outlook
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
End-use Outlook
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
Service Outlook
Contract
In-house
Regional Outlook
North America
The U.S.
Canada
Europe
Germany
The U.K.
Asia Pacific
Japan
China
Latin America
Brazil
The Middle East and Africa (MEA)
South Africa
The Genome Editing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Genome Editing market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Genome Editing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Genome Editing market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Genome Editing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Genome Editing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Genome Editing by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Genome Editing market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Genome Editing market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Genome Editing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Genome Editing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Genome Editing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Genome Editing market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Genome Editing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Genome Editing market. These factors have benefited the growth of the global market for Genome Editing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Genome Editing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Genome Editing are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Genome Editing Market, By Technology
7.1. Genome Editing Market, by Technology, 2020-2030
7.1.1. (CRISPR)/Cas9
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. TALENs/MegaTALs
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. ZFN
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Others
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Genome Editing Market, By Delivery Method
8.1. Genome Editing Market, by Delivery Method, 2020-2030
8.1.1. Ex-Vivo
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. In-Vivo
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Genome Editing Market, By Application
9.1. Genome Editing Market, by Application, 2020-2030
9.1.1. Cell Line Engineering
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Animal Genetic Engineering
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Plant Genetic Engineering
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Other Applications
9.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Genome Editing Market, By End-use
10.1. Genome Editing Market, by End-use, 2020-2030
10.1.1. Biotechnology & Pharmaceutical Companies
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Academic & Government Research Institutes
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Contract Research Organizations
10.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Genome Editing Market, By Component
11.1. Genome Editing Market, by Component, 2020-2030
11.1.1. Contract
11.1.1.1. Market Revenue and Forecast (2016-2030)
11.1.2. In-house
11.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 12. Global Genome Editing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Technology (2016-2030)
12.1.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.1.3. Market Revenue and Forecast, by Application (2016-2030)
12.1.4. Market Revenue and Forecast, by End-use (2016-2030)
12.1.5. Market Revenue and Forecast, by Component (2016-2030)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, by Technology (2016-2030)
12.1.6.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.1.6.4. Market Revenue and Forecast, by End-use (2016-2030)
12.1.6.5. Market Revenue and Forecast, by Component (2016-2030)
12.1.7. Rest of North America
12.1.7.1. Market Revenue and Forecast, by Technology (2016-2030)
12.1.7.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.1.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.1.7.4. Market Revenue and Forecast, by End-use (2016-2030)
12.1.7.5. Market Revenue and Forecast, by Component (2016-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Technology (2016-2030)
12.2.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.2.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.4. Market Revenue and Forecast, by End-use (2016-2030)
12.2.5. Market Revenue and Forecast, by Component (2016-2030)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, by Technology (2016-2030)
12.2.6.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.6.4. Market Revenue and Forecast, by End-use (2016-2030)
12.2.6.5. Market Revenue and Forecast, by Component (2016-2030)
12.2.7. Germany
12.2.7.1. Market Revenue and Forecast, by Technology (2016-2030)
12.2.7.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.7.4. Market Revenue and Forecast, by End-use (2016-2030)
12.2.7.5. Market Revenue and Forecast, by Component (2016-2030)
12.2.8. France
12.2.8.1. Market Revenue and Forecast, by Technology (2016-2030)
12.2.8.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.8.4. Market Revenue and Forecast, by End-use (2016-2030)
12.2.8.5. Market Revenue and Forecast, by Component (2016-2030)
12.2.9. Rest of Europe
12.2.9.1. Market Revenue and Forecast, by Technology (2016-2030)
12.2.9.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.2.9.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.9.4. Market Revenue and Forecast, by End-use (2016-2030)
12.2.9.5. Market Revenue and Forecast, by Component (2016-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Technology (2016-2030)
12.3.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.3.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.4. Market Revenue and Forecast, by End-use (2016-2030)
12.3.5. Market Revenue and Forecast, by Component (2016-2030)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, by Technology (2016-2030)
12.3.6.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.6.4. Market Revenue and Forecast, by End-use (2016-2030)
12.3.6.5. Market Revenue and Forecast, by Component (2016-2030)
12.3.7. China
12.3.7.1. Market Revenue and Forecast, by Technology (2016-2030)
12.3.7.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.7.4. Market Revenue and Forecast, by End-use (2016-2030)
12.3.7.5. Market Revenue and Forecast, by Component (2016-2030)
12.3.8. Japan
12.3.8.1. Market Revenue and Forecast, by Technology (2016-2030)
12.3.8.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.8.4. Market Revenue and Forecast, by End-use (2016-2030)
12.3.8.5. Market Revenue and Forecast, by Component (2016-2030)
12.3.9. Rest of APAC
12.3.9.1. Market Revenue and Forecast, by Technology (2016-2030)
12.3.9.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.3.9.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.9.4. Market Revenue and Forecast, by End-use (2016-2030)
12.3.9.5. Market Revenue and Forecast, by Component (2016-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Technology (2016-2030)
12.4.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.4.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.4. Market Revenue and Forecast, by End-use (2016-2030)
12.4.5. Market Revenue and Forecast, by Component (2016-2030)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, by Technology (2016-2030)
12.4.6.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.6.4. Market Revenue and Forecast, by End-use (2016-2030)
12.4.6.5. Market Revenue and Forecast, by Component (2016-2030)
12.4.7. North Africa
12.4.7.1. Market Revenue and Forecast, by Technology (2016-2030)
12.4.7.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.7.4. Market Revenue and Forecast, by End-use (2016-2030)
12.4.7.5. Market Revenue and Forecast, by Component (2016-2030)
12.4.8. South Africa
12.4.8.1. Market Revenue and Forecast, by Technology (2016-2030)
12.4.8.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.8.4. Market Revenue and Forecast, by End-use (2016-2030)
12.4.8.5. Market Revenue and Forecast, by Component (2016-2030)
12.4.9. Rest of MEA
12.4.9.1. Market Revenue and Forecast, by Technology (2016-2030)
12.4.9.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.4.9.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.9.4. Market Revenue and Forecast, by End-use (2016-2030)
12.4.9.5. Market Revenue and Forecast, by Component (2016-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Technology (2016-2030)
12.5.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.5.3. Market Revenue and Forecast, by Application (2016-2030)
12.5.4. Market Revenue and Forecast, by End-use (2016-2030)
12.5.5. Market Revenue and Forecast, by Component (2016-2030)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, by Technology (2016-2030)
12.5.6.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.5.6.4. Market Revenue and Forecast, by End-use (2016-2030)
12.5.6.5. Market Revenue and Forecast, by Component (2016-2030)
12.5.7. Rest of LATAM
12.5.7.1. Market Revenue and Forecast, by Technology (2016-2030)
12.5.7.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.5.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.5.7.4. Market Revenue and Forecast, by End-use (2016-2030)
12.5.7.5. Market Revenue and Forecast, by Component (2016-2030)
Chapter 13. Company Profiles
13.1. Caribou Biosciences, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Sangamo, Editas Medicine
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Recombinetics, Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Thermo Fisher Scientific, Inc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. CRISPR THERAPEUTICS
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Intellia Therapeutics
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Sigma Aldrich Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
Glossary of Terms